These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9336438)

  • 21. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome.
    Tuisku IS; Konttinen YT; Konttinen LM; Tervo TM
    Exp Eye Res; 2008 Jun; 86(6):879-85. PubMed ID: 18436208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretory immune system and mucosal immunohistology in Sjogren's syndrome.
    Celenligil H; Kansu E; Ruacan S; Eratalay K
    Adv Exp Med Biol; 1987; 216B():1641-8. PubMed ID: 3425452
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
    Pijpe J; Kalk WW; Vissink A
    J Rheumatol; 2003 Jan; 30(1):206-7; author reply 207. PubMed ID: 12508418
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal Fas antigen and the pathobiology of Sjögren's syndrome.
    De Vita S
    Clin Exp Rheumatol; 1996; 14(3):231-4. PubMed ID: 8809435
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis).
    Mitsias DI; Kapsogeorgou EK; Moutsopoulos HM
    Lupus; 2006; 15(5):255-61. PubMed ID: 16761498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Alm GV; Rönnblom L
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of apoptosis in Sjögren's syndrome.
    Bolstad AI; Jonsson R
    Ann Med Interne (Paris); 1998 Feb; 149(1):25-9. PubMed ID: 11490513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Sjögren's syndrome: the challenge for classification of disease manifestations.
    Oxholm P; Asmussen K
    J Intern Med; 1996 Jun; 239(6):467-74. PubMed ID: 8656139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sjögren's syndrome pathophysiology].
    Mariette X
    Rev Med Interne; 2010 Jun; 31 Suppl 1():S2-6. PubMed ID: 20398979
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenetic aspects of humoral autoimmunity in Sjögren's syndrome.
    Tatouli IP; Tzioufas AG
    Lupus; 2012 Oct; 21(11):1151-4. PubMed ID: 22898537
    [No Abstract]   [Full Text] [Related]  

  • 34. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sjogren's syndrome and the danger model.
    Bredberg A; Henriksson G; Larsson A; Manthorpe R; Sallmyr A
    Rheumatology (Oxford); 2005 Aug; 44(8):965-70. PubMed ID: 15840601
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopathology of Sjögren's syndrome.
    Tapinos NI; Polihronis M; Tzioufas AG; Skopouli FN
    Ann Med Interne (Paris); 1998 Feb; 149(1):17-24. PubMed ID: 11490512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic manifestations in Sjögren's syndrome.
    Sugai S
    Intern Med; 2001 Apr; 40(4):269-70. PubMed ID: 11334381
    [No Abstract]   [Full Text] [Related]  

  • 38. New insights into the physiopathology of primary Sjögren's syndrome.
    Moutsopoulos HM
    Ann Med Interne (Paris); 1990; 141(1):53-6. PubMed ID: 2181901
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical aspects of Sjögren's syndrome].
    Ofuji T
    Ryumachi; 1983 Feb; 23(1):50-8. PubMed ID: 6867870
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome.
    Lin DF; Yan SM; Zhao Y; Zhang W; Li MT; Zeng XF; Zhang FC; Dong Y
    Chin Med J (Engl); 2010 Nov; 123(22):3252-7. PubMed ID: 21163125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.